Atara seeks new CEO as Isaac Ciechanover exits; AstraZeneca's Mark Mallon tapped to replace Peter Hecht at Ironwood
→ In an abrupt departure, Isaac Ciechanover is stepping down from Atara Biotherapeutics $ATRA, the T cell therapy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
